bf/NASDAQ:GH_icon.png

NASDAQ:GH

Guardant Health, Inc.

  • Stock

48.87

+3.47%

−9.70

USD last updated 14/08 01:46:41

Last Close

58.57

13/08 20:36

Market Cap

3.38B

Beta: 0.81

Volume Today

4.74M

Avg: 1.90M

PE Ratio

−5.81

PFCF: −7.12

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy data...Show More

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52018-03-302019-11-072021-11-042023-11-062024-11-06

    Revenue (Estimate*)

    50M100M150M200M2018-03-302019-11-072021-11-042023-11-062024-11-06

    *Estimate based on analyst consensus